1. Home
  2. SNGX vs MOVE Comparison

SNGX vs MOVE Comparison

Compare SNGX & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • MOVE
  • Stock Information
  • Founded
  • SNGX 1987
  • MOVE 2018
  • Country
  • SNGX United States
  • MOVE United States
  • Employees
  • SNGX N/A
  • MOVE N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SNGX Health Care
  • MOVE Health Care
  • Exchange
  • SNGX Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • SNGX 6.5M
  • MOVE 7.3M
  • IPO Year
  • SNGX 1987
  • MOVE 2021
  • Fundamental
  • Price
  • SNGX $2.17
  • MOVE $0.86
  • Analyst Decision
  • SNGX
  • MOVE Buy
  • Analyst Count
  • SNGX 0
  • MOVE 1
  • Target Price
  • SNGX N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • SNGX 198.8K
  • MOVE 45.3K
  • Earning Date
  • SNGX 05-09-2025
  • MOVE 04-09-2025
  • Dividend Yield
  • SNGX N/A
  • MOVE N/A
  • EPS Growth
  • SNGX N/A
  • MOVE N/A
  • EPS
  • SNGX N/A
  • MOVE N/A
  • Revenue
  • SNGX $119,371.00
  • MOVE $1,013,000.00
  • Revenue This Year
  • SNGX N/A
  • MOVE $1,460.71
  • Revenue Next Year
  • SNGX N/A
  • MOVE N/A
  • P/E Ratio
  • SNGX N/A
  • MOVE N/A
  • Revenue Growth
  • SNGX N/A
  • MOVE N/A
  • 52 Week Low
  • SNGX $1.68
  • MOVE $0.71
  • 52 Week High
  • SNGX $14.83
  • MOVE $8.85
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 52.69
  • MOVE 21.11
  • Support Level
  • SNGX $1.97
  • MOVE $0.78
  • Resistance Level
  • SNGX $2.21
  • MOVE $0.99
  • Average True Range (ATR)
  • SNGX 0.15
  • MOVE 0.17
  • MACD
  • SNGX 0.03
  • MOVE 0.09
  • Stochastic Oscillator
  • SNGX 86.96
  • MOVE 26.01

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: